[1]
Andrey Emanuilov Manov, Ashan Thomas Hatharasinghe, and Katrina Equinox Lopez, “Comparison of the effect on Hyperglycemia and the Adverse Effects among Different GLP-1 Receptor Agonists Added to Basal Insulin and between GLP-1 Receptor Agonists and Basal Insulin Versus Basal-Plus or Basal-Bolus Insulin in Type 2 Diabetes: A Meta-Analysis”, NFMMR-V10, pp. 147–163, Aug. 2021.